Phoenix Life Sciences International Is Now Accepting Bids for Hemp CBD Producers and Manufacturers
12 déc. 2018 09h00 HE
|
Phoenix Life Sciences International
DENVER, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that it is...
Phoenix Life Sciences International Announces the Release of the Company’s Investor Relations Deck and Accompanying Video Presentation
06 déc. 2018 09h00 HE
|
Phoenix Life Sciences International
DENVER, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that it...
Phoenix Life Sciences International Announces Angus Stewart as Company’s New Agriculture and Horticulture Senior Advisor
28 nov. 2018 09h00 HE
|
Phoenix Life Sciences International
DENVER, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that Angus...
Phoenix Life Sciences Receives Import Certificate for Cannabis Diabetes Drug from the Republic of Vanuatu
14 nov. 2018 09h00 HE
|
Phoenix Life Sciences International
DENVER, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTCMarkets: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced...
Phoenix Life Sciences International Announces Significant Retirement of Convertible Debt and Elimination of Outstanding Preferred Shares
13 nov. 2018 09h00 HE
|
Phoenix Life Sciences International
DENVER , Nov. 13, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (“Phoenix Life”) (OTC: PLSI), an international adaptive healthcare solutions company, today announced that it...
Phoenix Life Sciences International Receives Approval for Name Change, Symbol Change, and Completion of Consolidation of Businesses
05 nov. 2018 12h15 HE
|
Phoenix Life Sciences International
DENVER, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced it has...
Phoenix Life Sciences International Receives Approval for Name Change, Symbol Change, and Completion of Consolidation of Businesses
02 nov. 2018 09h00 HE
|
Phoenix Life Sciences International
DENVER, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced it has...
Phoenix Life Sciences International Announces Dr. Philip Blair as Diabetes Director of Medical Advisory Council
25 oct. 2018 09h45 HE
|
Phoenix Life Sciences International
DENVER, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTCMarkets: MJMD) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced...
Phoenix Life Sciences International Receives Government Approval to Produce Botanical Pharmaceutical Products in South Pacific
10 oct. 2018 09h00 HE
|
Phoenix Life Sciences International
DENVER, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTCMarkets: MJMD) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced...
Phoenix Life Sciences International Announces New Board of Directors and Executive Team
03 oct. 2018 09h00 HE
|
Phoenix Life Sciences International
DENVER, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTC: MJMD) (“Phoenix Life”), an adaptive healthcare solutions company, today announced its new Board of...